Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

NIPT 9.77 -0.10 (-1.06%)
price chart
Premaitha Health PLC Premaitha Health signs Investment Agreement with Thermo ...
Premaitha's CE-marked, non-invasive prenatal screening (NIPT) product, the IONA� test, runs on Thermo Fisher's two sequencing instruments, the Ion Proton and Ion Chef.
Premaitha Health PLC 131.7% Potential Upside Indicated by finnCap
Premaitha Health PLC using EPIC/TICKER code LON:NIPT had its stock rating noted as 'Initiates/Starts' with the recommendation being set at 'CORPORATE' this morning by analysts at finnCap.
Premaitha Health PLC's (NIPT) Corporate Rating Reaffirmed at FinnCap
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating restated by FinnCap in a report issued on Monday.
Premaitha Health PLC's (NIPT) "Buy" Rating Reiterated at ...  Community Financial News
Premaitha Health Plc (LON:NIPT) target price held steady to GBX20, reported ...  Breaking Finance News
-LSE Ticker: N31ZD8/ISIN: GB00BN31ZD89
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom.
Panmure Gordon retained Premaitha Health Plc (LON:NIPT) as 'Buy' With 24 PT
Premaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques.
Are Analysts Bullish Premaitha Health PLC (LON:NIPT) After Last Week?
Out of 2 analysts covering Premaitha Health Plc (LON:NIPT), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive.
Recent Research Analysts' Ratings Updates for Premaitha Health PLC (NIPT)
3/29/2016 - Premaitha Health PLC had its “buy” rating reaffirmed by analysts at Panmure Gordon. They now have a GBX 24 ($0.34) price target on the stock.
What's Ahead for Premaitha Health PLC After Today's Huge Increase?
The stock of Premaitha Health PLC (LON:NIPT) is a huge mover today! The stock increased 7.12% or GBX 0.53 on July 25, hitting GBX 7.9.
Premaitha Health (LON:NIPT) Analyst Target Prices
Premaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques.
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company  London South East
Related articles »